NOVARTIS N (Germany) Technical Analysis
| NOT Stock | EUR 143.42 1.56 1.10% |
As of the 28th of February, NOVARTIS N secures the Risk Adjusted Performance of 0.3294, mean deviation of 0.794, and Market Risk Adjusted Performance of 1.87. Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of NOVARTIS N, as well as the relationship between them.
NOVARTIS N Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NOVARTIS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NOVARTISNOVARTIS |
NOVARTIS N 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NOVARTIS N's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NOVARTIS N.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in NOVARTIS N on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding NOVARTIS N or generate 0.0% return on investment in NOVARTIS N over 90 days. NOVARTIS N is related to or competes with ROCHE HLDG, DANAHER (DAPSG), and BANK OF CHINA. NOVARTIS N is entity of Germany. It is traded as Stock on MU exchange. More
NOVARTIS N Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NOVARTIS N's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NOVARTIS N upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.6678 | |||
| Information Ratio | 0.3378 | |||
| Maximum Drawdown | 4.95 | |||
| Value At Risk | (1.01) | |||
| Potential Upside | 2.1 |
NOVARTIS N Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NOVARTIS N's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NOVARTIS N's standard deviation. In reality, there are many statistical measures that can use NOVARTIS N historical prices to predict the future NOVARTIS N's volatility.| Risk Adjusted Performance | 0.3294 | |||
| Jensen Alpha | 0.4017 | |||
| Total Risk Alpha | 0.3147 | |||
| Sortino Ratio | 0.5089 | |||
| Treynor Ratio | 1.86 |
NOVARTIS N February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.3294 | |||
| Market Risk Adjusted Performance | 1.87 | |||
| Mean Deviation | 0.794 | |||
| Downside Deviation | 0.6678 | |||
| Coefficient Of Variation | 234.09 | |||
| Standard Deviation | 1.01 | |||
| Variance | 1.01 | |||
| Information Ratio | 0.3378 | |||
| Jensen Alpha | 0.4017 | |||
| Total Risk Alpha | 0.3147 | |||
| Sortino Ratio | 0.5089 | |||
| Treynor Ratio | 1.86 | |||
| Maximum Drawdown | 4.95 | |||
| Value At Risk | (1.01) | |||
| Potential Upside | 2.1 | |||
| Downside Variance | 0.446 | |||
| Semi Variance | (0.12) | |||
| Expected Short fall | (1.09) | |||
| Skewness | 0.7417 | |||
| Kurtosis | 0.8324 |
NOVARTIS N Backtested Returns
NOVARTIS N appears to be very steady, given 3 months investment horizon. NOVARTIS N has Sharpe Ratio of 0.41, which conveys that the firm had a 0.41 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for NOVARTIS N, which you can use to evaluate the volatility of the firm. Please exercise NOVARTIS N's Risk Adjusted Performance of 0.3294, market risk adjusted performance of 1.87, and Mean Deviation of 0.794 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, NOVARTIS N holds a performance score of 32. The company secures a Beta (Market Risk) of 0.23, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NOVARTIS N's returns are expected to increase less than the market. However, during the bear market, the loss of holding NOVARTIS N is expected to be smaller as well. Please check NOVARTIS N's potential upside, accumulation distribution, price action indicator, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether NOVARTIS N's current price movements will revert.
Auto-correlation | 0.91 |
Excellent predictability
NOVARTIS N has excellent predictability. Overlapping area represents the amount of predictability between NOVARTIS N time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NOVARTIS N price movement. The serial correlation of 0.91 indicates that approximately 91.0% of current NOVARTIS N price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.91 | |
| Spearman Rank Test | 0.86 | |
| Residual Average | 0.0 | |
| Price Variance | 32.95 |
NOVARTIS N technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NOVARTIS N Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for NOVARTIS N across different markets.
About NOVARTIS N Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NOVARTIS N on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NOVARTIS N based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NOVARTIS N price pattern first instead of the macroeconomic environment surrounding NOVARTIS N. By analyzing NOVARTIS N's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NOVARTIS N's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NOVARTIS N specific price patterns or momentum indicators. Please read more on our technical analysis page.
NOVARTIS N February 28, 2026 Technical Indicators
Most technical analysis of NOVARTIS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NOVARTIS from various momentum indicators to cycle indicators. When you analyze NOVARTIS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.3294 | |||
| Market Risk Adjusted Performance | 1.87 | |||
| Mean Deviation | 0.794 | |||
| Downside Deviation | 0.6678 | |||
| Coefficient Of Variation | 234.09 | |||
| Standard Deviation | 1.01 | |||
| Variance | 1.01 | |||
| Information Ratio | 0.3378 | |||
| Jensen Alpha | 0.4017 | |||
| Total Risk Alpha | 0.3147 | |||
| Sortino Ratio | 0.5089 | |||
| Treynor Ratio | 1.86 | |||
| Maximum Drawdown | 4.95 | |||
| Value At Risk | (1.01) | |||
| Potential Upside | 2.1 | |||
| Downside Variance | 0.446 | |||
| Semi Variance | (0.12) | |||
| Expected Short fall | (1.09) | |||
| Skewness | 0.7417 | |||
| Kurtosis | 0.8324 |
NOVARTIS N February 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as NOVARTIS stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.02 | ||
| Daily Balance Of Power | 0.53 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 141.95 | ||
| Day Typical Price | 142.44 | ||
| Price Action Indicator | 2.25 | ||
| Market Facilitation Index | 2.94 |
Additional Tools for NOVARTIS Stock Analysis
When running NOVARTIS N's price analysis, check to measure NOVARTIS N's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOVARTIS N is operating at the current time. Most of NOVARTIS N's value examination focuses on studying past and present price action to predict the probability of NOVARTIS N's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOVARTIS N's price. Additionally, you may evaluate how the addition of NOVARTIS N to your portfolios can decrease your overall portfolio volatility.